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eliana@ufp.edu.pAbstract The purpose of this work was to introduce a new concept of coated pellets containing
chitosan microspheres loaded with didadosine for oral administration, aiming at reducing the
frequency of administration and improving the bioavailability by a suitable release proﬁle.
Chitosan microspheres were produced under ﬂuidized bed, followed by extrusion and spheroniza-
tion to obtain pellets with a mean diameter of about 1 mm. The pellets were then coated with
Kollidons VA64 and Kollicoats MAE100P in water dispersion to depict a sustained release
proﬁle. Conventional hard gelatine capsules were loaded with these pellets and tested in vitro for
their release proﬁle of didadosine. Dissolution testing conﬁrmed that chitosan microsphere pellets
provides appropriate sustained release up to 2 h behavior for didanosine.
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Didadosine-loaded chitosan microspheres pellets 1891. Introduction
Didanosine is a drug commonly used in acquired immune
deﬁciency syndrome (AIDS) therapy [1,2]. Although it may
suffer hydrolysis in acid pH, which consequently produces
hypoxanthine, concomitant administration of didanosine with
food may still compromise the stability of the drug due to the
acid pH generated by the digestion process. In general, the
free drug is administered in buffered tablets to prevent its
deactivation when exposed to the low pH of the stomach. The
tablet formulation requires the addition of 50% of carbonate
or magnesium hydroxide to obtain the buffering effect.
However, some collateral effects are referred, such as diarrhea
and renal problems, and may also show wide inter-individual
bioavailability [3,4]. Furthermore, the buffered tablets are
large; being therefore, difﬁcult to be administered orally.
Great beneﬁts in didanosine administration were obtained in
2001 with the commercial formulation Videxs EC composed
of gastro-resistant granules. However, Videxs EC still
requires frequent administration and lacks in controlled
release proﬁle. Furthermore, the lower bioavailability makes
didanosine a good candidate for extended release formula-
tions. For pharmacokinetic analysis of didanosine in vivo, we
have recently published our ﬁrst attempt in validating an
automated system using on-line solid extraction and high
performance liquid chromatography (HPLC) with ultraviolet
(UV) detection [5].
In recent years, a continuous interest has been focused on the
development of controlled drug release formulations using multi-
particulate systems (e.g., pellets), offering various advan-
tages over single dosage forms, namely, an improved bioavail-
ability [6,7] and easy administration for elderly people and for
children [8]. These include a low risk of dose dumping, ﬂexi-
bility of blending units with different release patterns, reprodu-
cible gastric residence time, and prevention of high local drug
concentration in the gastrointestinal tract [9,10]. Because
of instability of didanosine in acid pH, sustained release
pellets have been frequently obtained using different types of
coatings [11].
The purpose of this work was to introduce a new concept of
coated pellets produced from chitosan microspheres loaded
with didadosine. Pellets were coated with different types of
formulations of polymers (Kollicoats MAE100P, Kollidons
VA64) and analyzed for their in vitro gastro-resistance after
encapsulation in hard capsules.2. Materials and methods
2.1. Materials
Didanosine was provided by Labogen Quı´mica Fina e Bio-
tecnologia S.A. (Indaiatuba, Brazil); Kollicoats MAE100P
and Kollidons VA64 were received as gifts from BASF (S~ao
Paulo, Brazil); Acetic acid and sodium tripolyphosphate
(TPP) were purchased from Synth (S~ao Paulo, Brazil).
Chitosan, of MW 296.6 kDa (approx.) and deacetylation
degree 82.8373.63%, was obtained from Polymar (Fortaleza,
Brazil). Microcrystalline cellulose was obtained by Henrifarma
(S~ao Paulo, Brazil). Distilled water was puriﬁed by a Milli-Q
system Millipores (S~ao Paulo, Brazil).2.2. Methods
2.2.1. Preparation of chitosan microspheres
Chitosan microspheres were prepared by ionotropic gelation
of chitosan and sodium tripolyphosphate (TPP) as cross-
linking agent, according to Santana et al. [12]. Brieﬂy, the
microspheres were formed by dropping an aqueous solution
composed of TPP (2 g/L), magnesium hydroxide (6 g/L) and
didanosine (39 g/L), to a chitosan aqueous solution (2.0% w/
v) previously acidiﬁed with acetic acid. The solutions were
mixed under stirring (2000 rpm) at 25 1C [5,13,14].
2.2.2. Preparation of uncoated pellets
The didanosine-loaded microspheres composed of chitosan, as
excipients, at a concentration of 4.8% (m/m) [13] were mixed and
the granulation was carried out by ﬂuidized bed or extrusion/
spheronization. The dry mass was processed by one of the
following methods: (a) ﬂuidized bed (Hu¨ttlin Instruments Com-
pany, model Microlab, Germany) with the following technical
parameters: volumetric ﬂow of air 6 m3/h, inlet air temperature
50 1C, temperature of pellets 40 1C, ﬂow pressure of 0.9 bar, with
the microclimate of 0.30 bar (internal pressure in ﬂuidized bed);
or (b) passed through a single screw extruder (Caleva Instru-
ments Company, model extruder 20, UK), with a 1.2 mm screen
at 20 rpm. The extrudates were processed in a spheronizer
(Spheronizer 250, Caleva Instruments Company, UK) ﬁtted with
a cross-hatched plate rotated at 100 rpm for about 5 min. The
obtained pellets in method (a) or (b) were dried at 40 1C for 2 h
in a ﬂuidized bed and sized by passing vibrating sieves (ELML
digital plus, Haver & Boecker, Brazil) through a 0.250 mm mesh
sieve, during 3 min, 7 s intervals and amplitude 1.
2.2.3. Preparation of coated pellets
The sub-coating and outer-coating solution was prepared
using Kollidons VA64 and Kollicoats MAE100P, respec-
tively, and according to Table 1. The pellets (40 g) were coated
in a ﬂuidized bed with the following technical parameters:
volumetric ﬂow of air 6 m3/h, inlet air temperature 50 1C,
temperature of pellets 40 1C, ﬂow pressure of 0.9 bar, with the
microclimate of 0.30 bar (internal pressure in ﬂuidized bed).
The coating dispersions were applied at a rate of 0.5 g/min
with the aid of a peristaltic pump (model 323, Watson
Marlow, Brazil). The minimum ﬂuidization was calculated
using the sphericity of 0.85, diameter of 100 mm, ﬂuid
viscosity of 1.927 105 kg/ms, ﬂuid density 10.95 kg/m3,
bed porosity of 0.216, bed height of 0.4 m and the pressure
ﬂuid through the bed of 4559.625 kg/m s2.
2.2.4. Characterization of the polymeric coating
The polymeric coatings Kollidons VA64 and Kollicoats
MAE100P were characterized by surface tension, contact angle
and work of adhesion. To assess the surface tension of the
coatings, the automatic tensiometer (Future Digital Scientiﬁc,
OCA-20, USA) was used. The strain was determined from a drop
of ﬂuid formed within a glass bottle and its image was projected
through a camera, through a speciﬁc software, measuring the
drop and providing the surface tension. The contact angle
measurements were performed by optical method using a manual
goniometer (Tantec, Germany). The method consists of deposit-
ing a drop of suspension on a ﬂat surface to determine the contact
angle. The light focuses on that drop, projecting on a screen
Table 1 Composition of sub-coating and outer-coating solutions used for the production of pellets (% m/v).
Coatings Composition 1 2 3 4 5 6 7
Sub-coating Kollidons VA64 (%) 5 – 5 10 10 10 10
Water (mL) 30 – 60 100 30 30 30
Outer-coating Kollicoats MAE 100 P (%) 10 20 30 20 10 20 30
Propylene glycol (%) 2.25 2.25 2.25 2.5 1.5 1.5 1.5
Magnesium trisilicate (%) 4 4 4 4 0.5 0.5 0.5
Titanium dioxide (%) – – – 2 0.5 0.5 0.5
Alcohol (mL) – – – – 100 100 100
Water (mL) 30 50 60 100
nPellets produced by ﬂuidized bed.
nnPellets produced by extrusion/spheronization.
Table 2 Geometric parameters of pellets produced by
ﬂuidized bed (Formulations 1–4) and by extrusion/
spheronization (Formulations 5–7) in comparison to
a commercial formulation.
Formulation Elongation Sphericity Feret diameter
(mm)
1 1.7070.82 0.9070.24 0.2570.18
2 1.5870.71 0.9270.25 0.1970.16
3 1.6370.72 0.8170.20 0.7070.38
4 1.4870.46 0.8170.28 0.4970.29
5 1.2370.26 0.7670.11 1.1170.16
6 1.4571.20 0.6670.17 1.2870.48
7 1.2570.48 0.7470.15 1.0570.26
Videxs EC 1.4370.31 0.8670.10 1.5270.28
P. Severino et al.190graduate. Chitosan microspheres were pressed into a stainless
steel ﬂask with the aid of a hydraulic press using 2 t forming a
disk. Measurements were performed at 25 1C, 65% relative
humidity, and in three different ways: (1) Deposition of Kolli-
dons VA64 solution directly on the disk; (2) Deposition of
Kollicoats MAE 100 P solution directly on the disk; and (3)
Coating the disk press with Kollidons VA64, following the
drying of Kollicoats MAE100P. The work of adhesion was
determined using the Neumann and Good equation [15].
WAD ¼ sLV ð1þ cosyÞ
where sLV is the surface tension between liquid and gas phases
and y is the angle of contact. High values indicate a good WAD
wetness for each set solid–liquid.
2.2.5. Characterization of coated pellets
The granules were characterized by determining the growth,
morphological and geometrical parameters. The geometric
parameters were determined by analyzing digital photographs
of pellets scattered on a black surface, obtained with a digital
camera SONY Cyber-shot 5 megapixel camera. The photo-
graphs were processed by UTHSCSA Image Tool 3.0 pro-
gram. The determined geometric parameters were the area,
perimeter and elongation. Sphericity and Feret diameter were
determined applying the following equations [16]:
Sphericity¼ 4pAr
Pm2
Feret diameter¼
ﬃﬃﬃﬃﬃﬃﬃﬃ
4Ar
p
r
where Ar and Pm stand, respectively, for the area and
perimeter of the microspheres. For the morphologies of the
external structure, a stereoscopic camera was used coupled
with ﬁber optic lighting (Motic Industrial Instruments, SMZ-
168, USA).
2.2.6. Dissolution test
Dissolution testing of the pellets was performed using USP28-
NF26 Apparatus II (paddle) at 75 rpm starting with 750 mL
solution at 3770.5 1C. The preparation method of the
dissolution medium was as follows. Firstly, pellets were placed
in a 0.1 M HCl solution for 120 min and samples were
collected every 30 min repeated to 120 min. Then, 250 mL of
0.05 M phosphate buffer was added and pH was adjusted with
a solution sodium hydroxide (NaOH) to pH 6.8. Samples werecollected every 30 min up to 120 min. The samples were
analyzed at 248 nm (UV-7504, UV/vis spectrophotometer,
Vankel Instrument Company, USA), selected on the basis of
the obtained highest peak absorbance.3. Results and discussion
Porosity at minimum ﬂuidization was calculated to fall
pressure in the ﬂuidized bed of 5%, and 40 cm of minimum
ﬂuidization height. The difference between the real and ﬂuid
density was 1481.905 kg/m3, and gravity was 9.81 m/s2. A
porosity of 21.6% was obtained, demonstrating the easiness of
ﬂuidization for this type of microspheres.
The values obtained by measuring the surface tension of the
Kollidons VA64 and Kollicoats MAE100P coatings were,
respectively, 49.2 mN/m and 34.8 mN/m. Determination of con-
tact angle (representing the mean value of 10 measures) of
polymers Kollidons VA64, Kollicoats MAE100P, and Kolli-
dons VA64/Kollicoats MAE100P were, respectively,
41.80171.75, 28.33174.63, and 37.60173.23.
For the contact angle, the obtained values were below 901,
showing the wetting properties of the disk in all cases.
Comparing the two methodologies employed for Kollicoats
MAE100P, the contact angle was greater than those sub-
coated with Kollidons VA64, reﬂecting lower water absorp-
tion due to the decreased superﬁcial energy. The work of
adhesion calculated from Kollidon s VA64 and Kollicoats
MAE100P was, respectively, 86.29 mN/m and 65.42 mN/m.
Figure 1 Photographs of pellets obtained by stereoscopy.
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Figure 2 Release proﬁle of didanosine vs time from hard gelatine
capsules containing pellets produced by ﬂuidized bed (Formula-
tions 1–4).
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Figure 3 Release proﬁles of didanosine vs time from hard
gelatine capsules containing pellets produced by extrusion/spher-
onization (Formulations 5–7).
Didadosine-loaded chitosan microspheres pellets 191This value was 83.27% of the maximum work of adhesion
(W¼78.56 mN/m) corresponding to 01, where complete
spreading occurs.
For the formulations 1, 2, 3 and 4 (Table 1), it was not
possible to determine the growth of microspheres due to the
formation of clusters, whereas for the formulations 5, 6 and 7,
the growth was, respectively, 10, 20 and 30% based on the
microspheres size without coating. Table 2 shows the geo-
metric parameters determined for the coated pellets, analyzingelongation data. The results approaching the reference
(Videxs EC) were obtained for formulation 4. The sphericity
values obtained were higher than 0.80, and were considered
satisfactory [17,18]. The Feret diameters were lower in com-
parison to the value considered suitable (i.e. 1 mm) for ﬁlling
hard gelatine capsules [19,20].
Formulations 1, 2, 3 and 4 showed irregular surface, which
has been attributed to the pellets obtained with low adherence
of the polymer on the surface pellets, due to the irregular
geometry. Fig. 1 shows the pellets obtained with the formula-
tions 5, 6 and 7.
The drug release proﬁles of formulations 1, 2, 3 and 4 are
depicted in Fig. 2 showing a burst didanosine release. Those
obtained with formulations 5, 6 and 7 depicted a controlled
release and gastro-resistant properties (Fig. 3), possibly attrib-
uted to the type of solvent used. For the formulations 1, 2, 3, 4
water was used to solubilize Kollicoat sMAE 100 P, while for
5, 6, 7 alcohol was used. That prevented the agglomeration of
the pellets and the formation of a complete and uniform
coverage.4. Conclusions
Controlled release and gastro-resistant pellets loading didano-
sine were successfully prepared using microspheres of chitosan
and coating of polymers by ﬂuidized bed following extrusion/
spheronization. Results showed satisfactory morphological
and dissolution properties for didanosine and this technology
can be useful for other drugs, promoting higher compliance to
HIV patients. The pellets have suitable shape and appropriate
hardness for the coating process and may be suitable for
subsequent in vivo experiments.Acknowledgments
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